257 related articles for article (PubMed ID: 19558187)
1. Size limitation in translocation of fibroblast growth factor 1 fusion proteins across the endosomal membrane.
Zakrzewska M; Zhen Y; Wiedlocha A; Olsnes S; Wesche J
Biochemistry; 2009 Aug; 48(30):7209-18. PubMed ID: 19558187
[TBL] [Abstract][Full Text] [Related]
2. Two nuclear localization signals required for transport from the cytosol to the nucleus of externally added FGF-1 translocated into cells.
Wesche J; Małecki J; Wiedłocha A; Ehsani M; Marcinkowska E; Nilsen T; Olsnes S
Biochemistry; 2005 Apr; 44(16):6071-80. PubMed ID: 15835896
[TBL] [Abstract][Full Text] [Related]
3. Translocation of exogenous FGF1 into cytosol and nucleus is a periodic event independent of receptor kinase activity.
Zakrzewska M; Sørensen V; Jin Y; Wiedlocha A; Olsnes S
Exp Cell Res; 2011 Apr; 317(7):1005-15. PubMed ID: 21223966
[TBL] [Abstract][Full Text] [Related]
4. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
[TBL] [Abstract][Full Text] [Related]
5. Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors.
Haugsten EM; Sørensen V; Brech A; Olsnes S; Wesche J
J Cell Sci; 2005 Sep; 118(Pt 17):3869-81. PubMed ID: 16091423
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements of FGF-1 for receptor binding and translocation into cells.
Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
Biochemistry; 2006 Dec; 45(51):15338-48. PubMed ID: 17176056
[TBL] [Abstract][Full Text] [Related]
7. Design of fully active FGF-1 variants with increased stability.
Zakrzewska M; Krowarsch D; Wiedlocha A; Otlewski J
Protein Eng Des Sel; 2004 Aug; 17(8):603-11. PubMed ID: 15469994
[TBL] [Abstract][Full Text] [Related]
8. Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation.
Kostas M; Lampart A; Bober J; Wiedlocha A; Tomala J; Krowarsch D; Otlewski J; Zakrzewska M
J Mol Biol; 2018 Oct; 430(21):4087-4101. PubMed ID: 30099027
[TBL] [Abstract][Full Text] [Related]
9. Externally added aFGF mutants do not require extensive unfolding for transport to the cytosol and the nucleus in NIH/3T3 cells.
Wesche J; Wiedłocha A; Falnes PO; Choe S; Olsnes S
Biochemistry; 2000 Dec; 39(49):15091-100. PubMed ID: 11106487
[TBL] [Abstract][Full Text] [Related]
10. Diphtheria toxin as a molecular tool in the study of acidic fibroblast growth factor signalling.
Wiedłocha A
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):391-409. PubMed ID: 9437495
[TBL] [Abstract][Full Text] [Related]
11. Symmetric primary and tertiary structure mutations within a symmetric superfold: a solution, not a constraint, to achieve a foldable polypeptide.
Brych SR; Dubey VK; Bienkiewicz E; Lee J; Logan TM; Blaber M
J Mol Biol; 2004 Nov; 344(3):769-80. PubMed ID: 15533444
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1.
Patrie KM; Botelho MJ; Franklin K; Chiu IM
Biochemistry; 1999 Jul; 38(29):9264-72. PubMed ID: 10413500
[TBL] [Abstract][Full Text] [Related]
13. Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action.
Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
J Mol Biol; 2005 Sep; 352(4):860-75. PubMed ID: 16126225
[TBL] [Abstract][Full Text] [Related]
14. Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding.
Backhaus R; Zehe C; Wegehingel S; Kehlenbach A; Schwappach B; Nickel W
J Cell Sci; 2004 Apr; 117(Pt 9):1727-36. PubMed ID: 15075234
[TBL] [Abstract][Full Text] [Related]
15. Determination of the topology of the hydrophobic segment of mammalian diacylglycerol kinase epsilon in a cell membrane and its relationship to predictions from modeling.
Decaffmeyer M; Shulga YV; Dicu AO; Thomas A; Truant R; Topham MK; Brasseur R; Epand RM
J Mol Biol; 2008 Nov; 383(4):797-809. PubMed ID: 18801368
[TBL] [Abstract][Full Text] [Related]
16. Translokin is an intracellular mediator of FGF-2 trafficking.
Bossard C; Laurell H; Van den Berghe L; Meunier S; Zanibellato C; Prats H
Nat Cell Biol; 2003 May; 5(5):433-9. PubMed ID: 12717444
[TBL] [Abstract][Full Text] [Related]
17. Isolation of neural stem/progenitor cells by using EGF/FGF1 and FGF1B promoter-driven green fluorescence from embryonic and adult mouse brains.
Lee DC; Hsu YC; Chung YF; Hsiao CY; Chen SL; Chen MS; Lin HK; Chiu IM
Mol Cell Neurosci; 2009 Jul; 41(3):348-63. PubMed ID: 19409495
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of fibroblast growth factor-1 traffick, signaling and release.
Maciag T; Friesel RE
Thromb Haemost; 1995 Jul; 74(1):411-4. PubMed ID: 8578497
[No Abstract] [Full Text] [Related]
19. Localization patterns of fibroblast growth factor 1 and its receptors FGFR1 and FGFR2 in postnatal mouse retina.
Catalani E; Tomassini S; Dal Monte M; Bosco L; Casini G
Cell Tissue Res; 2009 Jun; 336(3):423-38. PubMed ID: 19408015
[TBL] [Abstract][Full Text] [Related]
20. Retrograde transport of acidic fibroblast growth factor as a part of the growth factor signaling.
Wiedłocha A
Arch Immunol Ther Exp (Warsz); 1996; 44(4):201-7. PubMed ID: 9017159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
